Anti Influenza Drugs Market Scope And Analysis

  • Report Code : TIPRE00025692
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi del mercato dei farmaci antinfluenzali e dei concorrenti entro il 2025-2031

Buy Now

Anti-influenza Drugs Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 6.8%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Tipo di prodotto
  • Peramivir
  • Zanamivir
  • Oseltamivir fosfato
  • Baloxavir Marboxil
  • Altri prodotti
By Canale di distribuzione
  • farmacie al dettaglio
  • farmacie ospedaliere
  • altri
By Geografia
  • Nord America
  • Europa
  • Asia-Pacifico
  • Sud e Centro America
  • Medio Oriente e Africa
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AstraZeneca plc
  • BIOCRYST PHARMACEUTICALS, INC.
  • DAIICHI SANKYO COMPANY, LIMITED.
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc.
  • Mylan N.V.
  • Novartis AG
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.